Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity

Food and Function

Volumn 5, Issue 6, 2014, Pages 1241-1249

  Qiao, Yi ^a   Sun, Jin ^a   Xia, Shufang ^a   Tang, Xue ^a   Shi, Yonghui ^a   Le, Guowei ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOCHEMISTRY; BIOSYNTHESIS; CORRELATION METHODS; FLUORESCENCE MICROSCOPY; FOOD STORAGE; GENE EXPRESSION; GLUCOSE; MAMMALS; METABOLISM; NUTRITION; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

BIFIDOBACTERIUM; BIOCHEMICAL MARKERS; ENTEROCOCCUS FAECALIS; FLUORESCENCE IN SITU HYBRIDIZATION; LIPID METABOLISMS; NEGATIVE CORRELATION; PEARSON'S CORRELATION COEFFICIENTS; SIGNALING PATHWAYS;

RESVERATROL;

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ANGIOPOIETIN; ANGPTL4 PROTEIN, MOUSE; FAS ANTIGEN; FAS PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESVERATROL; SCD1 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIFIDOBACTERIUM; BLOOD; BODY WEIGHT; DRUG EFFECTS; ENTEROCOCCUS FAECALIS; GASTROINTESTINAL TRACT; GENETICS; GLUCOSE BLOOD LEVEL; LACTOBACILLUS; LIPID DIET; LIPOGENESIS; LIVER; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; OBESITY; SIGNAL TRANSDUCTION;

ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE; ANGIOPOIETINS; ANIMALS; ANTIGENS, CD95; BIFIDOBACTERIUM; BLOOD GLUCOSE; BODY WEIGHT; DIET, HIGH-FAT; ENTEROCOCCUS FAECALIS; GASTROINTESTINAL TRACT; LACTOBACILLUS; LIPIDS; LIPOGENESIS; LIVER; MALE; MICE; MICROBIOTA; OBESITY; PPAR GAMMA; SIGNAL TRANSDUCTION; STEAROYL-COA DESATURASE; STILBENES;

EID: 84901654102     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c3fo60630a     Document Type: Article

References (47)

1. B. Rokholm et al., The levelling off of the obesity epidemic since the year 1999- A review of evidence and perspectives Obes. Rev. 2010 11 12 835 846
2. N. Alkhouri et al., Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis J. Biol. Chem. 2010 285 5 3428 3438
3. C. J. Lavie et al., Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J. Am. Coll. Cardiol. 2009 53 21 1925 1932
4. T. M. Powell A. Khera Therapeutic approaches to obesity Curr. Treat. Options Cardiovasc. Med. 2010 12 4 381 395
5. V. Robles Alonso F. Guarner Linking the gut microbiota to human health Br. J. Nutr. 2013 109 suppl. 2 S21 S26
6. F. Backhed et al., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc. Natl. Acad. Sci. U. S. A. 2007 104 3 979 984
7. B. S. Samuel J. I. Gordon A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism Proc. Natl. Acad. Sci. U. S. A. 2006 103 26 10011 10016
8. F. Backhed et al., The gut microbiota as an environmental factor that regulates fat storage Proc. Natl. Acad. Sci. U. S. A. 2004 101 44 15718 15723
9. J. Walker et al., Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations Food Funct. 2014 5 74 84
10. J. A. Baur D. A. Sinclair Therapeutic potential or resveratrol: the in vivo evidence Nat. Rev. Drug Discovery 2006 5 6 493 506
11. S. Kim et al., Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice Biochem. Pharmacol. 2011 81 11 1343 1351
12. X. H. Zhang et al., Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation Nutr. Res. Pract. 2012 6 4 286 293
13. U. Stervbo et al., A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine Food Chem. 2007 101 2 449 457
14. R. Zamora-Ros et al., Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort Br. J. Nutr. 2008 100 1 188 196
15. M. I. Kaldas et al., Resveratrol transport and metabolism by human intestinal Caco-2 cells J. Pharm. Pharmacol. 2003 55 3 307 312
16. [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration Life Sci. 2003 72 20 2219 2233
17. M. Azorín-Ortuño et al., Metabolites and tissue distribution of resveratrol in the pig Mol. Nutr. Food Res. 2011 55 8 1154 1168
18. C. Manach et al., Polyphenols: food sources and bioavailability Am. J. Clin. Nutr. 2004 79 727 747
19. J. A. Baur et al., Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006 444 7117 337 342
20. P. Trinder Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor Ann. Clin. Biochem. 1969 6 24 27
21. A. Schwiertz et al., Quantification of different Eubacterium spp. in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes Appl. Environ. Microbiol. 2000 66 1 375 382
22. E. G. Zoetendal et al., Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes Appl. Environ. Microbiol. 2002 68 9 4225 4232
23. A. H. Franks et al., Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes Appl. Environ. Microbiol. 1998 64 9 3336 3345
24. N. Kruse et al., Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood J. Immunol. Methods 1997 210 2 195 203
25. H. C. Towle Glucose and cAMP: adversaries in the regulation of hepatic gene expression Proc. Natl. Acad. Sci. U. S. A. 2001 98 24 13476 13478
26. C. Zhang et al., Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice ISME J. 2010 4 2 232 241
27. W. D. Xie et al., Enhanced peroxisomal b-oxidation metabolism in visceral adipose tissues of high-fat diet-fed obesity resistant C57BL/6 mice Exp. Ther. Med. 2011 2 2 309 315
28. C. A. Tennyson G. Friedman Microecology, obesity, and probiotics Curr. Opin. Endocrinol., Diabetes Obes. 2008 15 422 427
29. P. D. Cani et al., Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia Diabetologia 2007 50 11 2374 2383
30. Y. Qiao et al., Alterations of the gut microbiota in high-fat diet mice is strongly linked to oxidative stress Appl. Microbiol. Biotechnol. 2013 97 4 1689 1697
31. M. Larrosa et al., Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model J. Agric. Food Chem. 2009 57 6 2211 2220
32. G. Musso et al., Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders Curr. Opin. Lipidol. 2010 21 1 76 83
33. J. K. DiBaise et al., Gut microbiota and its possible relationship with obesity Mayo Clin. Proc. 2008 83 4 460 469
34. R. E. Ley et al., Obesity alters gut microbial ecology Proc. Natl. Acad. Sci. U. S. A. 2005 102 11070 11075
35. R. A. Kemperman et al., Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities Microbiology. 2010 156 Pt11 3224 3231
36. T. W. Sirk et al., Molecular binding of catechins to biomembranes: relationship to biological activity J. Agric. Food Chem. 2009 57 15 6720 6728
37. A. H. Smith R. I. Mackie The effect of condensed tannins on bacterial diversity and metabolic activity in the rat gastrointestinal tract Appl. Environ. Microbiol. 2004 70 2 1104 1115
38. N. Fei L. Zhao An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice ISME J. 2012 7 4 880 884
39. S. Vendrame et al., Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut J. Agric. Food Chem. 2011 59 24 12815 12820
40. A. M. Neyrinck et al., Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota Br. J. Nutr. 2013 109 5 802 809
41. K. Preiss-Landl et al., Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism Curr. Opin. Lipidol. 2002 13 5 471 481
42. R. Gutiérrez-Juárez et al., Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance J. Clin. Invest. 2006 116 6 1686 1695
43. T. Li et al., Transgenic expression of cholesterol 7α-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice Hepatology. 2010 52 2 678 690
44. R. Siersbaek et al., PPARgamma in adipocyte differentiation and metabolism-novel insights from genome-wide studies FEBS Lett. 2010 584 15 3242 3249
45. Y. Shen L. Tong Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1 Biochemistry 2008 47 21 5767 5773
46. E. S. Pizer et al., Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells Cancer Res. 1996 56 4 745 751
47. A. Brunani et al., Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients Diabetes, Obes. Metab. 2008 10 6 460 467